-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATI-2138 in Psoriasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATI-2138 in Psoriasis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATI-2138 in Psoriasis Drug Details: ATI-2138 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATI-2138 in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATI-2138 in Ulcerative Colitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATI-2138 in Ulcerative Colitis Drug Details: ATI-2138 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATI-2138 in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATI-2138 in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATI-2138 in Atopic Dermatitis (Atopic Eczema) Drug Details: ATI-2138...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Docetaxel in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Docetaxel in Cervical Cancer Drug Details: docetaxel (ATI-1123) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Etrumadenant in Bladder Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Etrumadenant in Bladder Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Etrumadenant in Bladder Cancer Drug Details: AB-928 is under development for...
-
Product Insights
NewQuarterly Yogurt pricing trends in Brazil
Empower your strategies with our Quarterly Yogurt pricing trends in Brazil report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewQuarterly Milk pricing trends in Brazil
Empower your strategies with our Quarterly Milk pricing trends in Brazil report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewOrthocell Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Orthocell Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Orthocell Ltd (Orthocell) is a regenerative medicine company. The company develops and commercializes medical devices and cellular therapies for the treatment of human tendons, bone, nerve and cartilage defects. It offers CelGro, a collagen medical device for repair and regeneration of dental bones and soft tissues. Orthocell is also evaluating its products to treat nerve and tendon injuries. The company...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adavosertib in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adavosertib in Laryngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adavosertib in Laryngeal Cancer Drug Details: Adavosertib (AZD-1775, MK-1775) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Docetaxel in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Docetaxel in Non-Small Cell Lung Cancer Drug Details: docetaxel (ATI-1123)...